An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
Gerardo Rosati(Ospedale San Carlo), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Michele Montrone(Istituto Tumori Bari), Giuseppe Cicero(University of Palermo), Carmen Pacilio(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Fernando Paragliola(Ospedale San Carlo), Alfredo Colombo, Angelo Vaia(Ospedale San Carlo), Luigi Annunziata(University of Naples Federico II)
Cited by 2
Related Papers
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
|Journal of Clinical Oncology|2011|763
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|452
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group
|Journal of Clinical Oncology|2000|177
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
|Oncotarget|2016|166
Lapatinib in breast cancer
|Annals of Oncology|2007|129